Global /South Korea /Healthcare /Biotechnology /304840

PeopleBio, Inc.

304840

• KRX: 304840 • Delayed

1,400KRW 3.9%

0.9173 USD

As of 13 June 2026, PeopleBio, Inc. has a market cap of $21.56M USD, ranking #36595 globally and #2312 in South Korea. It ranks #3284 in the Healthcare sector, and #640 in the Biotechnology industry.

Global Rank

36595

Country Rank

2312

Sector Rank

3284

Industry Rank

640

Key Stats

Market Cap

$21.56MUSD

32.78B KRW

Enterprise Value

$26.7MUSD

40.75B KRW

Revenue (TTM)

$1.87MUSD

2.85B KRW

EBITDA (TTM)

-$6.85MUSD

-10.45B KRW

Net Income (TTM)

-$10.33MUSD

-15.71B KRW

PS Ratio

11.5

PB Ratio

1.1

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Sungmin Kang open_in_new

Employees

Founded

2002

Website

peoplebio.net open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
3.9%	-1.1%	86%	7.7%	-9.7%	26%	-52%	-85%	-94%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	304840 (주)피플바이오 Ordinary Shares ISIN: KR7304840002 Shares Out.: Shares Outstanding: 24.263M¹ Shares Float: 20.759M² TV: TradingView: KRX: 304840 SA: Stock Analysis: KRX: 304840 YF: Yahoo Finance: 304840.KS GF: Google Finance: KRX: 304840 BA: Barron's: 304840 MS: Morningstar: XKRX: 304840	1,400 KRW	TV: TradingView: KRX: 304840 SA: Stock Analysis: KRX: 304840 YF: Yahoo Finance: 304840.KS GF: Google Finance: KRX: 304840 BA: Barron's: 304840 MS: Morningstar: XKRX: 304840

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About PeopleBio, Inc.

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam-si, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 208K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 130K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.37B 20.33T KRW 62K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.51B 8.37T KRW 25K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.99B 6.07T KRW 18K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.25B 3.42T KRW 10K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 846K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 742K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 222K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 196K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 196K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 128K%	-	United States

chevron_leftBack